We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 562.00
Bid: 540.00
Ask: 570.00
Change: 0.00 (0.00%)
Spread: 30.00 (5.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 562.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of non-executive director

23 Feb 2012 12:45

RNS Number : 0031Y
Gooch & Housego PLC
23 February 2012
 



For immediate release

23 February 2012

 

Gooch & Housego PLC

 

Appointment of non-executive director

 

Gooch & Housego PLC, the specialist manufacturer of optical components and systems, today announces that Mr Mark Webster and Dr Peter Bordui were appointed to the Board as non-executive Directors at the board meeting held on 22nd February 2012.

 

Mark Webster, 50, has over twenty five years' experience in the healthcare industry in senior leadership roles for Abbott Laboratories, Shire Pharmaceuticals, Bayer Healthcare and ProStrakan. He is currently a director and Chief Executive Officer of Bio Products Laboratory Ltd. Previous roles include: -

 

·; Non-executive director of Abcam plc

·; Head of Global Strategic Marketing and North America for ProStrakan

·; Senior Vice President and Head of Global Strategic Marketing and Licensing/ Acquisitions for Bayer Healthcare and a member of Bayer's Pharmaceutical Management Committee

·; Head of Global Strategic Marketing and Licensing/Acquisitions for Shire Pharmaceuticals and a member of the Executive Committee

·; Head of the Pharmaceutical and Hospital Divisions in the UK, the Hospital Division in Canada and latterly as Vice President, Anti-Virals, US Pharmaceutical Division for Abbott Laboratories

 

Mr Webster holds an honours degree in Chemistry from the University of Durham.

 

Peter Bordui, 51, has twenty-five years' experience in the photonics industry in senior leadership roles with Bookham, New Focus, JDSU and Crystal Technology (at the time a subsidiary of Siemens), and has held a number of additional non-executive director roles. He is currently a non-executive director of M-Squared Lasers Ltd., BeamExpress S.A. and Media Lario International S.A. He is also a governing trustee of a private charitable foundation in his home state of Wisconsin, and director of the non-profit organisation American Citizens Abroad.

 

Previous roles include: -

 

·; President, CEO and Chairman of Bookham (initially listed on the London Stock Exchange and subsequently listed on NASDAQ)

·; Lead independent director of NASDAQ-listed New Focus, Inc.

·; Non-executive Chairman of Photonic Materials Ltd.

·; Non-executive director of Intense Photonics Ltd.

·; Vice President and General Manager of the Source Laser business at JDSU, Inc. (previously Uniphase Corporation)

·; Vice President of Crystal Technology responsible for the materials business (Crystal Technology LLC was acquired by Gooch & Housego in 2011)

·; Director of Polytech Ventures, a Swiss-based investment fund

 

Dr Bordui has bachelors, masters and PhD degrees from MIT.

 

Mr Webster and Dr Bordui will sit on the Audit, Remuneration and Nomination Committees of the Gooch & Housego PLC Board.

 

There are no other disclosures required under Schedule Two (g) of the AIM rules.

 

Gareth Jones, Chief Executive of Gooch & Housego, commented:

 

"Mark Webster and Peter Bordui bring extensive business skills and in-depth knowledge of the healthcare and photonics sectors to the board. Gooch & Housego is fortunate to be able to benefit from their wisdom and experience."

 

For further information please contact: -

 

Gareth Jones/Andrew Boteler

Gooch & Housego PLC

 

Tim Thompson/Nicola Cronk

Buchanan

 

Patrick Robb/James Grace

Investec Bank plc

Tel: 01460 256440

 

 

Tel: 020 7466 5000

 

 

Tel: 020 7597 5970

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABDGDDSSDBGDX
Date   Source Headline
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.